Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Changes in Surgical Management of the Axilla Over 11 Years - Report on More Than 1500 Breast Cancer Patients Treated with Neoadjuvant Chemotherapy on the Prospective I-SPY2 Trial.
Journal: Annals of surgical oncology
Published: March 22, 2023
Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial.
Journal: JAMA oncology
Published: September 16, 2021
Ductal carcinoma in situ in the male-to-female transgender population.
Journal: The breast journal
Published: August 09, 2020
Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial.
Journal: JAMA oncology
Published: July 24, 2020
Axillary Response in Patients Undergoing Neoadjuvant Endocrine Treatment for Node-Positive Breast Cancer: Systematic Literature Review and NCDB Analysis.
Journal: Annals of surgical oncology
Published: May 14, 2020
MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 08, 2020
Adaptive Randomization of Neratinib in Early Breast Cancer.
Journal: The New England journal of medicine
Published: July 14, 2016
Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.
Journal: The New England journal of medicine
Published: July 14, 2016
The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 11, 2014
Pilot phase I/II personalized therapy trial for metastatic colorectal cancer: evaluating the feasibility of protein pathway activation mapping for stratifying patients to therapy with imatinib and panitumumab.
Journal: Journal of proteome research
Published: May 03, 2014
Attacking breast cancer at the preinvasion stage by targeting autophagy.
Journal: Women's health (London, England)
Published: March 13, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026